$100K - $150K*
Principal Scientist, Pharmacometrics (DMPK)
Denali Therapeutics is dedicated to developing breakthrough therapies for neurodegenerative diseases through our deep commitment to degeneration biology and principles of translational medicine.
The Company is seeking to hire a Principal Scientist, Pharmacometrics specializing in elucidation of quantitative translational PK/PD relationships for novel small molecule and protein therapeutics. The incumbent will work cross-functionally with Biologists and Biomarker Scientists to design and conduct PK/PD studies, analyze data, interpret results, and provide strategic guidance to project teams. Additionally, collaborations with colleagues within Development Sciences, Clinical Pharmacology, and Clinical Development will be required to conduct PK/PD analysis for early clinical studies. The successful candidate will build additional internal capability and infras
Valid through: 2020-5-19
$200K - $250K
11 days ago